Literature DB >> 26395167

Objective assessment of isotretinoin-associated cheilitis: Isotretinoin Cheilitis Grading Scale.

Jennifer Ornelas1, Lorraine Rosamilia2, Larissa Larsen3, Negar Foolad3, Quinlu Wang4, Chin-Shang Li5, Raja K Sivamani3.   

Abstract

IMPORTANCE: Isotretinoin remains an effective treatment for severe acne. Despite its effectiveness, it includes many side effects, of which cheilitis is the most common.
OBJECTIVE: To develop an objective grading scale for assessment of isotretinoin-associated cheilitis.
DESIGN: Cross-sectional clinical grading study.
SETTING: UC Davis Dermatology clinic. PARTICIPANTS: Subjects were older than 18 years old and actively treated with oral isotretinoin. EXPOSURES: Oral Isotretinoin. MAIN OUTCOMES AND MEASURES: We developed an Isotretinoin Cheilitis Grading Scale (ICGS) incorporating the following four characteristics: erythema, scale/crust, fissures and inflammation of the commissures. Three board-certified dermatologists independently graded photographs of the subjects.
RESULTS: The Kendall's coefficient of concordance (KCC) for the ICGS was 0.88 (p < 0.0001). The Kendall's coefficient was ≥0.72 (p < 0.0001) for each of the four characteristics included in the grading scale. An image-based measurement for lip roughness statistically significantly correlated with the lip scale/crusting assessment (r = 0.52, p < 0.05). CONCLUSION AND RELEVANCE: The ICGS is reproducible and relatively simple to use. It can be incorporated as an objective tool to aid in the assessment of isotretinoin associated cheilitis.

Entities:  

Keywords:  Acne; cheilitis; isotretinoin; teledermatology

Mesh:

Substances:

Year:  2015        PMID: 26395167      PMCID: PMC4988812          DOI: 10.3109/09546634.2015.1086477

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  12 in total

1.  The new therapy schema of the various kinds of acne based on the mucosa-skin side effects of the retinoids.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło
Journal:  Cutan Ocul Toxicol       Date:  2011-11-21       Impact factor: 1.820

Review 2.  The pharmacoeconomics of acne treatment: where are we heading?

Authors:  Marc J Inglese; Alan B Fleischer; Steven R Feldman; Rajesh Balkrishnan
Journal:  J Dermatolog Treat       Date:  2008       Impact factor: 3.359

Review 3.  Management of severe acne.

Authors:  C C Zouboulis; V Bettoli
Journal:  Br J Dermatol       Date:  2015-07       Impact factor: 9.302

4.  Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris.

Authors:  Sadiye Kus; Dilek Gün; Zeynep Demirçay; Haydar Sur
Journal:  Int J Dermatol       Date:  2005-03       Impact factor: 2.736

5.  Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.

Authors:  Marius Rademaker
Journal:  Australas J Dermatol       Date:  2010-11       Impact factor: 2.875

6.  Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study.

Authors:  Jon A Halvorsen; Robert S Stern; Florence Dalgard; Magne Thoresen; Espen Bjertness; Lars Lien
Journal:  J Invest Dermatol       Date:  2010-09-16       Impact factor: 8.551

7.  The prevalence of acne in adults 20 years and older.

Authors:  Christin N Collier; Julie C Harper; Jennifer A Cafardi; Wendy C Cantrell; Wenquan Wang; K Wade Foster; Boni E Elewski
Journal:  J Am Acad Dermatol       Date:  2007-10-22       Impact factor: 11.527

8.  Efficacy of vitamin E to prevent dermal complications of isotretinoin.

Authors:  Farideh Goforoushan; Hamideh Azimi; Mohamad Goldust
Journal:  Pak J Biol Sci       Date:  2013-06-01

9.  The effect of evening primrose oil for the prevention of xerotic cheilitis in acne patients being treated with isotretinoin: a pilot study.

Authors:  Kui Young Park; Eun Jung Ko; In Su Kim; Kapsok Li; Beom Joon Kim; Seong Jun Seo; Myeung Nam Kim; Chang Kwun Hong
Journal:  Ann Dermatol       Date:  2014-11-26       Impact factor: 1.444

10.  Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris.

Authors:  Parinitha K Rao; Ramesh M Bhat; B Nandakishore; Sukumar Dandakeri; Jacintha Martis; Ganesh H Kamath
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

View more
  2 in total

1.  Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience.

Authors:  Vincenzo Bettoli; Aurora Guerra-Tapia; Maria Isabel Herane; Jaime Piquero-Martín
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-12-30

2.  Creatine Phosphokinase Values during Low Starting Dose Isotretinoin Therapy.

Authors:  Marco Manfredini; Vincenzo Bettoli; Riccardo Forconi; Lucrezia Pacetti; Francesca Farnetani; Monica Corazza; Giovanni Pellacani
Journal:  Skin Appendage Disord       Date:  2020-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.